Mirum Pharmaceuticals, Inc. (MIRM)
Nasdaq: MIRM · CIK 0001759425 · United States
Every official Mirum Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open MIRM filings
Mirum Pharmaceuticals, Inc. documents
- Mirum Pharmaceuticals, Inc. 10-K 2026MIRM 10-K 2026: annual report for fiscal 2026
- Mirum Pharmaceuticals, Inc. 10-K 2025MIRM 10-K 2025: annual report for fiscal 2025
- Mirum Pharmaceuticals, Inc. 10-K 2024MIRM 10-K 2024: annual report for fiscal 2024
- Mirum Pharmaceuticals, Inc. 10-K 2023MIRM 10-K 2023: annual report for fiscal 2023
- Mirum Pharmaceuticals, Inc. 10-K 2022MIRM 10-K 2022: annual report for fiscal 2022
- Mirum Pharmaceuticals, Inc. 10-Q 2026MIRM 10-Q 2026: quarterly report for fiscal 2026
- Mirum Pharmaceuticals, Inc. 10-Q 2025MIRM 10-Q 2025: quarterly report for fiscal 2025
- Mirum Pharmaceuticals, Inc. 10-Q 2024MIRM 10-Q 2024: quarterly report for fiscal 2024
- Mirum Pharmaceuticals, Inc. 10-Q 2023MIRM 10-Q 2023: quarterly report for fiscal 2023
- Mirum Pharmaceuticals, Inc. 10-Q 2022MIRM 10-Q 2022: quarterly report for fiscal 2022
- Mirum Pharmaceuticals, Inc. 8-K 2026MIRM 8-K 2026: current report for fiscal 2026
- Mirum Pharmaceuticals, Inc. 8-K 2025MIRM 8-K 2025: current report for fiscal 2025
- Mirum Pharmaceuticals, Inc. 8-K 2024MIRM 8-K 2024: current report for fiscal 2024
- Mirum Pharmaceuticals, Inc. 8-K 2023MIRM 8-K 2023: current report for fiscal 2023
- Mirum Pharmaceuticals, Inc. 8-K 2022MIRM 8-K 2022: current report for fiscal 2022
- Mirum Pharmaceuticals, Inc. DEF 14A 2026MIRM DEF 14A 2026: proxy statement for fiscal 2026
- Mirum Pharmaceuticals, Inc. DEF 14A 2025MIRM DEF 14A 2025: proxy statement for fiscal 2025
- Mirum Pharmaceuticals, Inc. DEF 14A 2024MIRM DEF 14A 2024: proxy statement for fiscal 2024
- Mirum Pharmaceuticals, Inc. DEF 14A 2023MIRM DEF 14A 2023: proxy statement for fiscal 2023
- Mirum Pharmaceuticals, Inc. DEF 14A 2022MIRM DEF 14A 2022: proxy statement for fiscal 2022
- Mirum Pharmaceuticals, Inc. Form 4 2026MIRM Form 4 2026: insider trading filing for fiscal 2026
- Mirum Pharmaceuticals, Inc. Form 4 2025MIRM Form 4 2025: insider trading filing for fiscal 2025
- Mirum Pharmaceuticals, Inc. Form 4 2024MIRM Form 4 2024: insider trading filing for fiscal 2024
- Mirum Pharmaceuticals, Inc. Form 4 2023MIRM Form 4 2023: insider trading filing for fiscal 2023
- Mirum Pharmaceuticals, Inc. Form 4 2022MIRM Form 4 2022: insider trading filing for fiscal 2022
- Mirum Pharmaceuticals, Inc. S-1 2026MIRM S-1 2026: registration statement for fiscal 2026
- Mirum Pharmaceuticals, Inc. S-1 2025MIRM S-1 2025: registration statement for fiscal 2025
- Mirum Pharmaceuticals, Inc. S-1 2024MIRM S-1 2024: registration statement for fiscal 2024
- Mirum Pharmaceuticals, Inc. S-1 2023MIRM S-1 2023: registration statement for fiscal 2023
- Mirum Pharmaceuticals, Inc. S-1 2022MIRM S-1 2022: registration statement for fiscal 2022
- Mirum Pharmaceuticals, Inc. 13F 2026MIRM 13F 2026: institutional holdings for fiscal 2026
- Mirum Pharmaceuticals, Inc. 13F 2025MIRM 13F 2025: institutional holdings for fiscal 2025
- Mirum Pharmaceuticals, Inc. 13F 2024MIRM 13F 2024: institutional holdings for fiscal 2024
- Mirum Pharmaceuticals, Inc. 13F 2023MIRM 13F 2023: institutional holdings for fiscal 2023
- Mirum Pharmaceuticals, Inc. 13F 2022MIRM 13F 2022: institutional holdings for fiscal 2022
More companies